Dr Lal PathLabs Launches SOVAAKA Wellness Centre in Gurugram, Expands Preventive Healthcare Portfolio

1767670760753.webp
Gurugram, January 6, 2026: Dr Lal PathLabs Limited (NSE: LALPATHLAB | BSE: 539524) on Tuesday announced the launch of SOVAAKA, a next-generation diagnostic and wellness centre in Gurugram, marking a strategic expansion into personalised preventive and lifestyle healthcare.

SOVAAKA has been positioned as a diagnostic experience centre built around the philosophy of “Science Behind Wellness,” combining precision diagnostics, advanced imaging, medical expertise and digital health integration under one roof. The initiative reflects the company’s focus on shifting healthcare delivery from reactive disease detection to proactive health prediction and early intervention.

The centre offers customised, doctor-designed wellness programmes tailored to age, gender and lifestyle needs. Key offerings include specialised programmes such as Eterna for women and Vita for men, supported by advanced diagnostic tools like high-sensitivity blood panels, genetic testing, AI-supported imaging and integrated digital health records. The model also includes end-to-end clinical report evaluation and personalised nutrition guidance to deliver a comprehensive health assessment.

SOVAAKA is equipped with facilities including low-dose CT, 1.5T MRI, DEXA scanning, genetic analysis, and a wide range of routine and advanced blood tests. According to the company, the integrated setup is designed to ensure faster turnaround times and deeper health insights through a single, personalised evaluation journey.

Commenting on the launch, Executive Chairman (Hony) Brig. Dr. Arvind Lal said the initiative represents a pivotal shift in the diagnostics landscape, emphasising early screening and science-led wellness to address the rising burden of lifestyle and non-communicable diseases. He noted that proactive testing can play a critical role in improving long-term health outcomes.

Chief Executive Officer Shankha Banerjee said SOVAAKA reimagines preventive healthcare delivery by bringing diagnostics, advanced imaging and lifestyle-based programmes together. He added that the centre is intended to serve individuals who are actively investing in long-term health management.

The launch comes amid rapid growth in India’s preventive health and wellness segment, driven by increasing lifestyle-related health risks, rising awareness and greater emphasis on early diagnosis. With SOVAAKA, Dr Lal PathLabs aims to strengthen its presence in evidence-backed preventive care solutions while expanding beyond traditional diagnostics.

About the Company​

Dr Lal PathLabs Limited is one of India’s leading diagnostics service providers, offering a wide range of diagnostic and related healthcare tests across the country. As of March 31, 2025, the company operated over 298 clinical laboratories, including a National Reference Lab in Delhi and Regional Reference Labs in Kolkata, Bengaluru and Mumbai, along with more than 6,600 patient service centres and over 12,300 pick-up points nationwide.

Source:
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Back
Top